RLA2_RHOGU
ID RLA2_RHOGU Reviewed; 110 AA.
AC Q96UQ7;
DT 01-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT 01-DEC-2001, sequence version 1.
DT 25-MAY-2022, entry version 57.
DE RecName: Full=60S acidic ribosomal protein P2;
DE AltName: Full=Acyl carrier protein;
OS Rhodotorula glutinis (Yeast).
OC Eukaryota; Fungi; Dikarya; Basidiomycota; Pucciniomycotina;
OC Microbotryomycetes; Sporidiobolales; Sporidiobolaceae; Rhodotorula.
OX NCBI_TaxID=5535 {ECO:0000312|EMBL:AAL30745.1};
RN [1] {ECO:0000305}
RP NUCLEOTIDE SEQUENCE [MRNA], PHOSPHOPANTETHEINYLATION AT SER-59, MUTAGENESIS
RP OF SER-12; SER-17; SER-19; SER-40; SER-59; SER-64; SER-67 AND SER-100, AND
RP IDENTIFICATION BY MASS SPECTROMETRY.
RX PubMed=12869567; DOI=10.1074/jbc.m305052200;
RA Raychaudhuri S., Rajasekharan R.;
RT "Nonorganellar acyl carrier protein from oleaginous yeast is a homologue of
RT ribosomal protein P2.";
RL J. Biol. Chem. 278:37648-37657(2003).
RN [2] {ECO:0000305}
RP SUBUNIT.
RX PubMed=11139581; DOI=10.1074/jbc.m009550200;
RA Gangar A., Karande A.A., Rajasekharan R.;
RT "Isolation and localization of a cytosolic 10 S triacylglycerol
RT biosynthetic multienzyme complex from oleaginous yeast.";
RL J. Biol. Chem. 276:10290-10298(2001).
CC -!- FUNCTION: Probable bifunctional protein. The phosphorylated protein
CC plays an important role in the elongation step of protein synthesis (By
CC similarity). The phosphopantetheinylated protein acts as an acyl
CC carrier protein. {ECO:0000250}.
CC -!- SUBUNIT: The phosphorylated form is part of the ribosomal stalk
CC involved in the interaction of the elongation factors with the ribosome
CC during protein synthesis (By similarity). The phosphopantetheinylated
CC form is part of the 10S triacylglycerol biosynthetic complex involved
CC in de novo fatty acid biosynthesis. {ECO:0000250,
CC ECO:0000269|PubMed:11139581}.
CC -!- SUBCELLULAR LOCATION: Cytoplasm.
CC -!- PTM: 4'-phosphopantetheine is transferred from CoA to a specific serine
CC by acpS. This modification is essential for activity because fatty
CC acids are bound in thioester linkage to the sulfhydryl of the
CC prosthetic group. {ECO:0000269|PubMed:12869567}.
CC -!- SIMILARITY: Belongs to the eukaryotic ribosomal protein P1/P2 family.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AF434667; AAL30745.1; -; mRNA.
DR AlphaFoldDB; Q96UQ7; -.
DR SMR; Q96UQ7; -.
DR GO; GO:0022625; C:cytosolic large ribosomal subunit; IEA:InterPro.
DR GO; GO:0005840; C:ribosome; NAS:UniProtKB.
DR GO; GO:0000036; F:acyl carrier activity; IDA:UniProtKB.
DR GO; GO:0003735; F:structural constituent of ribosome; NAS:UniProtKB.
DR GO; GO:0002182; P:cytoplasmic translational elongation; IEA:InterPro.
DR GO; GO:0006633; P:fatty acid biosynthetic process; IDA:UniProtKB.
DR GO; GO:0008610; P:lipid biosynthetic process; NAS:UniProtKB.
DR CDD; cd05833; Ribosomal_P2; 1.
DR Gene3D; 1.10.10.1410; -; 1.
DR HAMAP; MF_01478; Ribosomal_L12_arch; 1.
DR InterPro; IPR038716; P1/P2_N_sf.
DR InterPro; IPR027534; Ribosomal_L12/P1/P2.
DR InterPro; IPR044076; Ribosomal_P2.
DR PANTHER; PTHR21141; PTHR21141; 1.
PE 1: Evidence at protein level;
KW Cytoplasm; Fatty acid biosynthesis; Fatty acid metabolism;
KW Lipid biosynthesis; Lipid metabolism; Phosphopantetheine; Phosphoprotein;
KW Ribonucleoprotein; Ribosomal protein.
FT CHAIN 1..110
FT /note="60S acidic ribosomal protein P2"
FT /id="PRO_0000157680"
FT REGION 62..110
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 96..110
FT /note="Acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT MOD_RES 59
FT /note="O-(pantetheine 4'-phosphoryl)serine; in acyl carrier
FT protein form"
FT /evidence="ECO:0000269|PubMed:12869567"
FT MOD_RES 100
FT /note="Phosphoserine; in ribosomal stalk form"
FT /evidence="ECO:0000250"
FT MUTAGEN 12
FT /note="S->A: No change in acylation capacity."
FT /evidence="ECO:0000269|PubMed:12869567"
FT MUTAGEN 17
FT /note="S->A: No change in acylation capacity."
FT /evidence="ECO:0000269|PubMed:12869567"
FT MUTAGEN 19
FT /note="S->A: No change in acylation capacity."
FT /evidence="ECO:0000269|PubMed:12869567"
FT MUTAGEN 40
FT /note="S->A: No change in acylation capacity."
FT /evidence="ECO:0000269|PubMed:12869567"
FT MUTAGEN 59
FT /note="S->A: Abolishes acylation capacity."
FT /evidence="ECO:0000269|PubMed:12869567"
FT MUTAGEN 64
FT /note="S->A: No change in acylation capacity."
FT /evidence="ECO:0000269|PubMed:12869567"
FT MUTAGEN 67
FT /note="S->A: No change in acylation capacity."
FT /evidence="ECO:0000269|PubMed:12869567"
FT MUTAGEN 100
FT /note="S->A: No change in acylation capacity."
FT /evidence="ECO:0000269|PubMed:12869567"
SQ SEQUENCE 110 AA; 11098 MW; 14697B729910C781 CRC64;
MKHVAAYLLL VSAGNTSPSA EDVKKVLAAA DIQADEERLS VLIKELEGKD VNEVIAEGSK
KLASVPSGGA APAAAAGGAA AGGAAEEKAE DKPAEKDEES DDDMGFGLFD